We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MRVL market cap is 6.94M. The company's latest EPS is CAD -0.0368 and P/E is -4.08.
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | -2.58M | -1.66M | -2.12M | -1.27M |
| Net Income | -10k | -3.04M | -2.55M | -2.29M | -1.65M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 407k | 2.47M | 914k | 672k | 491k |
| Total Liabilities | 3k | 112k | 718k | 2.39M | 3.32M |
| Total Equity | 404k | 2.36M | 196k | -1.72M | -2.83M |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -9k | -1.37M | -2.19M | -1.33M | -1.18M |
| Investing | 10k | 382k | N/A | N/A | N/A |
| Financing | N/A | 3.16M | 394k | 1.3M | 969k |
| Market Cap | 6.94M |
| Price to Earnings Ratio | -4.08 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 19.48 |
| Price to Book Ratio | -2.38 |
| Dividend Yield | - |
| Shares Outstanding | 44.79M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (6.25%) |
| Company Name | Marvel Biosciences Corp |
| Address |
600, 815 8th avenue sw calgary, alberta T2P 3T2 |
| Website | https://marvelbiotechnology.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
